Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)

ClinicalTrials.gov ID: NCT02289846

Public ClinicalTrials.gov record NCT02289846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Study of Oral IW-9179 Administered Once and Twice Daily for 4 Weeks to Patients With Diabetic Gastroparesis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this study are to evaluate the safety of IW-9179 in patients with diabetic gastroparesis (DGP) and the effect of treatment on the cardinal symptoms of DGP.

Study identification

NCT ID
NCT02289846
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ironwood Pharmaceuticals, Inc.
Industry
Enrollment
90 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2014 (Type not available)
Primary completion
Dec 2015 (Actual)
Completion
Dec 2015 (Actual)
Last update posted
Dec 5, 2016

2014 – 2015

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Ironwood Investigational Site Birmingham Alabama 35203 —
Ironwood Investigational Site Dothan Alabama 36305 —
Ironwood Investigational Site Tucson Arizona 85710 —
Ironwood Investigational Site North Little Rock Arkansas 72117 —
Ironwood Investigational Site Chula Vista California 91910 —
Ironwood Investigational Site Los Angeles California 90036 —
Ironwood Investigational Site Ventura California 93003 —
Ironwood Investigational Site Miami Florida 33122 —
Ironwood Investigational Site Tampa Florida 33607 —
Ironwood Investigational Site Urbana Illinois 61801 —
Ironwood Investigational Site Bastrop Louisiana 71220 —
Ironwood Investigational Site Chesterfield Michigan 48047 —
Ironwood Investigational Site Rochester Minnesota 55905 —
Ironwood Investigational Site Great Neck New York 11023 —
Ironwood Investigational Site New York New York 10018 —
Ironwood Investigational Site Poughkeepsie New York 12601 —
Ironwood Investigational Site Greensboro North Carolina 27410 —
Ironwood Investigational Site Winston-Salem North Carolina 27103 —
Ironwood Investigational Site Chattanooga Tennessee 37421 —
Ironwood Investigational Site Houston Texas 77015 —
Ironwood Investigational Site Webster Texas 77598 —
Ironwood Investigational Site Ogden Utah 84405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02289846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2016 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02289846 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →